Interpretation of the group standard for operation
procedure of meibomian gland massage
Views:
16255
DOI:
10.12419/24102202
Publication Date:
2025/03/28
Author(s):
TIAN Bishan1, LI Shuping1, FU Qi1, DENG Yuqing1, XIAO Bing1, YUAN Jin1
TIAN Bishan1, LI Shuping1, FU Qi1, DENG Yuqing1, XIAO Bing1, YUAN Jin1
Institution/Unit:
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Meibomian gland dysfunction (MGD) can lead to an imbalance in the ocular surface microenvironment, eye discomfortable, and visual impairment, thereby profoundly affecting the visual quality of life of patients. Meibomian gland massage is now widely used in clinical patients, serving as the most prevalent physical therapy for MGD. The mechanism of meibomian gland massage is to open the meibomian gland opening by squeezing the meibomian gland and expel abnormal eyelid esters. However, due to the diverse techniques used in meibomian gland massage and the varying levels of operational experience accumulated by different medical institutions, there are many potential risks in treatment process. If medical staff operate improperly, it can cause eye infections, eyelid redness and swelling, conjunctival edema and bleeding, and even corneal damage. Therefore, it is crucial to establish the standardized procedure of meibomian gland massage therapy. Yet, there is currently lack of comprehensive, systematic, and standardized clinical practice guidance. Thus, the Zhongshan Ophthalmic Center, Sun Yat-sen University, in collaboration with 19 medical institutions across the country, has released the group standard for Operation Procedure of Meibomian Gland Massage on the National Group Standard Information Platform on December 17, 2023. This article aims to provide an in-depth interpretation of the group standard to guide clinical work better.
Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, et al. Global
prevalence of meibomian gland dysfunction: a systematic review and
meta-analysis[ J]. Ocul Immunol Inflamm, 2021, 29(1): 66-75. DOI:
10.1080/09273948.2020.1755441.
Nichols KK, Foulks GN, Bron AJ, et al. The international workshop
on meibomian gland dysfunction: executive summary[ J]. Invest
Ophthalmol Vis Sci, 2011, 52(4): 1922-1929. DOI: 10.1167/iovs.10-
6997a.
Daniel Nelson J, Shimazaki J, Benitez-del-Castillo JM, et al. The
international workshop on meibomian gland dysfunction: report of the
definition and classification subcommittee[ J]. Invest Ophthalmol Vis
Sci, 2011, 52(4): 1930-1937. DOI: 10.1167/iovs.10-6997b.
Asiedu K, Dzasimatu S, Kyei S. Impact of meibomian gland dysfunction
on quality of life and mental health in a clinical sample in Ghana: a
cross-sectional study[ J]. BMJ Open, 2022, 12(9): e061758. DOI:
10.1136/bmjopen-2022-061758.
Wei Z, Liang J, Cao K, et al. A multi-center study evaluating the
correlation between meibomian gland dysfunction and depressive
symptoms[ J]. Sci Rep, 2022, 12(1): 443. DOI: 10.1038/s41598-021-
04167-x.
亚洲干眼协会中国分会, 海峡两岸医药交流协会眼科专业
委员会眼表与泪液病学组. 我国蠕形螨睑缘炎诊断和治疗
专家共识(2018年)[ J]. 中华眼科杂志, 2018, 54(7): 491-495. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.004. Expert consensus
on diagnosis and treatment of demodex blepharitis in China (2018)
[ J]. Chin J Ophthal, 2018, 54(7): 491-495. DOI: 10.3760/cma.
j.issn.0412-4081.2018.07.004.
亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专
业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表
与干眼学组. 中国干眼专家共识: 免疫性疾病相关性干眼(2021
年)[ J]. 中华眼科杂志, 2021, 57(12): 898-907. DOI: 10.3760/cma.
j.cn112142-20210929-00466. Chinese expert consensus on dry eye: dry
eye related to immunologic diseases (2021)[ J]. Chin J Ophthal, 2021,
57(12): 898-907. DOI: 10.3760/cma.j.cn112142-20210929-00466.
刘小银, 周畅, 陈梅, 等 按摩在睑板腺功能障碍相关性干眼中
应用的最佳证据总结 [ J]. 中华现代护理杂志, 2024, 30(26):
3602-3607. DOI: 10.3760/cma.j.cn115682-20231213-02588. Liu XY,
Zhou C, Chen M et al. Summary of best evidence for the application
of massage in meibomian gland dysfunction-related dry eye [ J]. Chin J
Mod Nurs, 2024, 30(26): 3602-3607. DOI: 10.3760/cma.j.cn115682-
20231213-02588.
中国抗癌协会临床肿瘤学协作专业委员会. 肿瘤化疗所致血小
板减少症诊疗中国专家共识(2014版)[ J]. 中华肿瘤杂志, 2014,
36(11): 876-879. DOI: 10.3760/cma.j.issn.0253-3766.2014.11.016.
Expert consensus on diagnosis and treatment of chemotherapyinduced thrombocytopenia in cancer patients (2014 Version)
[ J]. Chin J Oncol, 2014, 36(11): 876-879. DOI: 10.3760/cma.
j.issn.0253-3766.2014.11.016.
Wang DH, Liu XQ, Hao XJ, et al. Effect of the meibomian gland
squeezer for treatment of meibomian gland dysfunction[ J]. Cornea,
2018, 37(10): 1270-1278. DOI: 10.1097/ICO.0000000000001682.
徐东, 祝宏英, 俞萍萍, 等. 睑板腺功能障碍患者物理治疗的并
发症观察[ J]. 浙江医学, 2019, 41(10): 1067-1069. DOI: 10.12056/
j.issn.1006-2785.2019.41.10.2018-2695. Xu D, Zhu HY, Yu PP, et al.
Observation on complications of physical therapy in patients with
meibomian gland dysfunction[ J]. Zhejiang Med J, 2019, 41(10): 1067-
1069. DOI: 10.12056/j.issn.1006-2785.2019.41.10.2018-2695.